These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6243953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate is enhanced by EDTA and diminished by zinc(II).
    Costas MJ, Cameselle JC.
    Biochem Int; 1988 Apr; 16(4):747-53. PubMed ID: 2839191
    [Abstract] [Full Text] [Related]

  • 3. Interaction between muscle aldolase and muscle fructose 1,6-bisphosphatase results in the substrate channeling.
    Rakus D, Pasek M, Krotkiewski H, Dzugaj A.
    Biochemistry; 2004 Nov 30; 43(47):14948-57. PubMed ID: 15554702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Muscle aldolase decreases muscle FBPase sensitivity toward AMP inhibition.
    Rakus D, Dzugaj A.
    Biochem Biophys Res Commun; 2000 Aug 28; 275(2):611-6. PubMed ID: 10964712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetic properties of D-fructose-1,6-bisphosphate 1-phosphohydrolase isolated from human muscle.
    Skalecki K, Mularczyk W, Dzugaj A.
    Biochem J; 1995 Sep 15; 310 ( Pt 3)(Pt 3):1029-35. PubMed ID: 7575399
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The origin of the high sensitivity of muscle fructose 1,6-bisphosphatase towards AMP.
    Rakus D, Maciaszczyk E, Wawrzycka D, Ułaszewski S, Eschrich K, Dzugaj A.
    FEBS Lett; 2005 Oct 24; 579(25):5577-81. PubMed ID: 16213487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New insight into the binding modes of TNP-AMP to human liver fructose-1,6-bisphosphatase.
    Han X, Huang Y, Zhang R, Xiao S, Zhu S, Qin N, Hong Z, Wei L, Feng J, Ren Y, Feng L, Wan J.
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug 05; 165():155-160. PubMed ID: 27137358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure of inhibited fructose-1,6-bisphosphatase from Escherichia coli: distinct allosteric inhibition sites for AMP and glucose 6-phosphate and the characterization of a gluconeogenic switch.
    Hines JK, Kruesel CE, Fromm HJ, Honzatko RB.
    J Biol Chem; 2007 Aug 24; 282(34):24697-706. PubMed ID: 17567577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Crystal structure of the neutral form of fructose 1,6-bisphosphatase complexed with regulatory inhibitor fructose 2,6-bisphosphate at 2.6-A resolution.
    Liang JY, Huang S, Zhang Y, Ke H, Lipscomb WN.
    Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2404-8. PubMed ID: 1312721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.